Logo 01A
Generic Name: aspirin/dipyridamole
Pill imprint Logo 01A has been identified as Aggrenox 25 mg / 200 mg.
Aggrenox is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy.
Aggrenox 25 mg / 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Aggrenox Images
- Generic Name:
- aspirin/dipyridamole
- Imprint:
-
Logo 01A
- Strength:
- 25 mg / 200 mg
- Color:
- Red & White
- Size:
- 24.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- acacia
aluminum stearate
silicon dioxide
corn starch
dimethicone
hypromellose
lactose monohydrate
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
povidone
stearic acid
sucrose
magnesium silicate
tartaric acid
titanium dioxide
triacetin
gelatin
ferric oxide red
ferric oxide yellow
water
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00597-0001
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5143 | Physicians Total Care Inc (repackager) |
| 68258-9022 | Dispensing Solutions Inc. (repackager) |
| 49999-0919 | Lake Erie Medical and Surgical Supply (repackager) |
| 21695-0656 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Aggrenox resources
- Aggrenox
- Aggrenox Extended-Release Capsules (Wolters Kluwer)
- Aggrenox (Cerner Multum)
- Aggrenox (Micromedex) - Includes Dosage Information
- Aggrenox (FDA)
Search Again
